- Home
- SGLY vs TLPH Comparison
SGLY vs TLPH Comparison
Compare SGLY & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- TLPH
- Stock Information
- Founded
- SGLY 2001
- TLPH 2005
- Country
- SGLY United States
- TLPH United States
- Employees
- SGLY N/A
- TLPH N/A
- Industry
- SGLY
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- SGLY
- TLPH Health Care
- Exchange
- SGLY Nasdaq
- TLPH Nasdaq
- Market Cap
- SGLY 3.9M
- TLPH 10.6M
- IPO Year
- SGLY 2008
- TLPH 2011
- Fundamental
- Price
- SGLY $1.11
- TLPH $0.45
- Analyst Decision
- SGLY
- TLPH Strong Buy
- Analyst Count
- SGLY 0
- TLPH 1
- Target Price
- SGLY N/A
- TLPH $6.00
- AVG Volume (30 Days)
- SGLY 53.3K
- TLPH 42.9K
- Earning Date
- SGLY 08-26-2025
- TLPH 08-13-2025
- Dividend Yield
- SGLY N/A
- TLPH N/A
- EPS Growth
- SGLY N/A
- TLPH N/A
- EPS
- SGLY N/A
- TLPH N/A
- Revenue
- SGLY $2,172,036.00
- TLPH $27,000.00
- Revenue This Year
- SGLY N/A
- TLPH N/A
- Revenue Next Year
- SGLY N/A
- TLPH $14,533.26
- P/E Ratio
- SGLY N/A
- TLPH N/A
- Revenue Growth
- SGLY N/A
- TLPH N/A
- 52 Week Low
- SGLY $0.54
- TLPH $0.43
- 52 Week High
- SGLY $7.65
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- SGLY 59.35
- TLPH 45.62
- Support Level
- SGLY $0.93
- TLPH $0.45
- Resistance Level
- SGLY $1.10
- TLPH $0.52
- Average True Range (ATR)
- SGLY 0.08
- TLPH 0.03
- MACD
- SGLY -0.01
- TLPH -0.00
- Stochastic Oscillator
- SGLY 78.26
- TLPH 35.33
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.